BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their ...

Researchers reveal how DICER precisely processes RNA using dual binding pockets, ensuring accurate gene silencing, and offering new insights for RNA therapeutics, and disease mechanisms.

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their ...

The stock was down 14% premarket after BioNTech announced the departures and issued revenue guidance that fell short of Wall ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

A research team from The Hong Kong University of Science and Technology (HKUST) has made a breakthrough discovery in understanding the molecular ...

Christine Dunham is a leading expert on the ribosome—an elaborate macro-molecular machine that operates like a factory within ...

One dog, one vaccine, one data point. The story of Rosie is fascinating – but it is not yet evidence that AI can beat cancer.

A team at UT Southwestern Medical Center has identified a structural trick that lets viruses translate their genetic code inside human cells, even when that code is riddled with “bad” codons the host ...

How can cells be programmed to respond to complex signals and make targeted decisions, similar to a logical circuit in a ...

Paul Conyngham, an Australian technology enthusiast, developed a custom mRNA vaccine for his cancer-stricken dog, Rosie.